文献速递耳科与耳神经小儿耳鼻咽喉

鼓膜通气管脱出后自体充气治疗分泌性中耳炎的随机临床试验

Autoinflation After Tympanostomy Tube Extrusion in Otitis Media With Effusion: A Randomized Clinical Trial.
PubMed 文献 · JAMA Otolaryngol Head Neck Surg · 2026-01-01

这项前瞻性随机临床试验纳入接受鼓膜通气管置入的慢性分泌性中耳炎患儿,通气管脱出后随机接受5周自体充气装置治疗或单纯观察。结果显示自体充气组复发率和再手术率均低于观察组,且安全性良好,支持其作为通气管脱出后维持中耳通气的无创康复策略。

要点

  • 通气管脱出后自体充气5周可降低分泌性中耳炎复发率(19.2% vs 35.7%)。
  • 自体充气组再手术率低于观察组(7.7% vs 28.6%)。
  • 自体充气安全可行,鼓室压图类型保持稳定。

核心结论

  • 通气管脱出后行自体充气安全可行,并与再次手术需求减少相关。
  • 复发率差异与具有临床意义的降低相一致,支持自体充气作为无创康复策略。

研究设计与样本

  • 前瞻性随机临床试验,2019年9月至2022年8月在一家三级医院开展。
  • 纳入接受鼓膜通气管置入的慢性分泌性中耳炎患儿,通气管脱出后随访2年。
  • 平均(SD)年龄55.5(18.5)个月,男性30名(55.6%)。
  • 统计分析于2024年3月至2025年2月进行。

主要发现

  • 自体充气组复发5/26(19.2%),观察组10/28(35.7%),差异16.5个百分点(95%CI -7.4至37.8)。
  • 自体充气组再手术2/26(7.7%),观察组8/28(28.6%),差异20.9个百分点(95%CI -0.29至40.2)。
  • 自体充气组鼓室压图A型从19/26(73.1%)变为20/26(76.9%),C型从7/26(26.9%)变为6/26(23.1%)。
  • 观察组A型从21/28(75.0%)降至16/28(57.1%),C型从7/28(25.0%)升至12/28(42.9%)。

临床怎么用

  • 对于鼓膜通气管脱出后的慢性分泌性中耳炎患儿,可考虑使用自体充气装置进行5周无创康复治疗。
  • 治疗期间应通过耳镜和鼓室压图评估中耳通气状态及复发情况。

局限性

  • 最终分析样本量较小(54名儿童),可能影响统计效能。
  • 复发率和再手术率差异的95%CI均包含0,需谨慎解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Otitis media with effusion (OME) is a common condition in children that can lead to hearing loss and developmental delays. Although tympanostomy tube (TT) placement is the standard treatment for persistent OME, recurrence after tube extrusion and the need for reoperation remain significant concerns. OBJECTIVE: To evaluate the clinical effectiveness of autoinflation in reducing OME recurrence and reoperation rates after TT extrusion in pediatric patients. DESIGN, SETTING, AND PARTICIPANTS: This prospective randomized clinical trial, conducted from September 2019 to August 2022 at a tertiary hospital, enrolled children with chronic OME who underwent TT placement with 2 years of follow-up after TT extrusion. The statistical analysis took place between March 2024 and February 2025. INTERVENTIONS: After TT extrusion, patients were randomized to receive autoinflation with the autoinflation device for 5 weeks or to undergo observation alone. MAIN OUTCOMES AND MEASURES: The main outcomes were OME recurrence and reoperation rates using otoscopic and tympanometric evaluations. RESULTS: Sixty-six children enrolled in the study; 54 were included in the final analysis (26 in the autoinflation group and 28 in the observation group). Among 54 children (mean [SD] age, 55.5 [18.5] months; 30 [55.6%] male), the recurrence rate was 5 of 26 patients (19.2%) in the autoinflation group and much higher at 10 of 28 patients (35.7%) in the observation group (difference, 16.5 percentage points [pp]; 95% CI, -7.4 pp to 37.8 pp), while the reoperation rate was much lower in the autoinflation group at 2 of 26 patients (7.7%) compared to the observation group at 8 of 28 patients (28.6%; difference, 20.9 pp; 95% CI,-0.29 pp to 40.2 pp). In the autoinflation group, tympanometry showed minimal change from the first follow-up after TT extrusion to after 5 weeks of autoinflation therapy (type A tympanogram: 19 of 26 patients [73.1%] to 20 of 26 patients [76.9%]; type C tympanogram: 7 of 26 patients [26.9%] to 6 of 26 patients [23.1%]). In contrast, the observation group exhibited a decline in type A tympanograms (21 of 28 patients [75.0%] to 16 of 28 patients [57.1%]) and an increase in type C tympanograms (7 of 28 patients [25.0%] to 12 of 28 patients [42.9%]). CONCLUSION AND RELEVANCE: In this randomized clinical trial, autoinflation after TT extrusion was safe, feasible, and associated with a reduced need for repeat surgical intervention. The observed difference in recurrence was compatible with a clinically meaningful reduction. These findings support the use of autoinflation as a noninvasive rehabilitative strategy to enhance eustachian tube function and maintain middle ear ventilation following TT extrusion. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT07122999.

来源:JAMA Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Na HS, Lee S, Kim SH, et al. Autoinflation After Tympanostomy Tube Extrusion in Otitis Media With Effusion: A Randomized Clinical Trial. JAMA Otolaryngol Head Neck Surg. 2026. PMID: 41817520. doi:10.1001/jamaoto.2026.0044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。